WASHINGTON – Pharmacogenomic testing for sensitivity to the blood thinner warfarin (Coumadin) looks like a great idea to FDA (Medical Device Daily, Aug. 20, 2007), but that might not be the majority view among members of the American Association for Clinical Chemistry (AACC; Washington) if an informal and utterly unscientific poll conducted on Monday is any indication. (Medical Device Daily)